News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Shilpa Gupta: Amazing to see our first patient on EV-302 still in CR after 3 years featured in our The Case Comprehensive Cancer Center Annual Report
Photo of Shilpa Gupta taken from X/Twitter
Apr 15, 2024, 11:15

Shilpa Gupta: Amazing to see our first patient on EV-302 still in CR after 3 years featured in our The Case Comprehensive Cancer Center Annual Report

Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared on X:

“Amazing to see our first patient on EV-302 (EV+P arm) still in CR after 3 years featured in our The Case Comprehensive Cancer Center  Annual Report EV+P sets the bar high for efficacy & QoL. Thanks to our patients & team at Cleveland Clinic for making this study a success. ”

Shilpa Gupta: Amazing to see our first patient on EV-302 still in CR after 3 years featured in our The Case Comprehensive Cancer Center Annual ReportShilpa Gupta: Amazing to see our first patient on EV-302 still in CR after 3 years featured in our The Case Comprehensive Cancer Center Annual ReportShilpa Gupta: Amazing to see our first patient on EV-302 still in CR after 3 years featured in our The Case Comprehensive Cancer Center Annual Report

Read further.
Source: Shilpa Gupta/X

Annual Report cancer Case Comprehensive Cancer Center Cleveland Clinic clinical trial efficacy EV-302 EVP OncoDaily Oncology patient success quality of life team effort.
Special Coverage
Insight
Dec 22, 2024, 00:21
Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed
Blog
Dec 21, 2024, 22:40
50 Years of History, a Future to Write Together - AIEOP
Science
Dec 21, 2024, 22:37
Breaking Down the Impact of Ionizing Radiation on Cancer
Blog
Dec 21, 2024, 22:35
Santiago Viteri: Latest findings from the BR.31 trial presented at the 2024 ESMO Congress
Blog
Dec 21, 2024, 22:33
ABIM will develop two new assessment options focusing on breast cancer and hematologic neoplasms
Blog
Dec 21, 2024, 22:28
Adekemi Oyewusi: EDUCARE - Supporting the medical treatment and education of those impacted by childhood cancer
Blog
Dec 21, 2024, 22:26
Anas Younes: Transforming outcomes for people living with Blood Cancer
Blog
Dec 21, 2024, 19:42
Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials
Blog
Dec 21, 2024, 19:39
Kyaw Thein: Investigational Treatments for Thyroid and Head and Neck Cancers
Blog
Dec 21, 2024, 19:25
Hesham ElGhazaly: From an academic institution into a globally recognized hub for healthcare, research and innovation
Blog
Dec 21, 2024, 19:21
Douglas Flora: The 19 Words I’m Learning to Embrace as a Leader in 2025
Blog
Dec 21, 2024, 19:19
Registration and abstract submission open for the PTCOG63 - SIOP Europe